BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Biotech Bay

  Bloodsource Launches Bloodsmart® App Now Available Through Apple App Store

  September 8, 2014

   · 

  2 min read
• Business

  Janssen Pharmaceutical Inc. And Johnson & Johnson Innovation Establish Research Collaboration With The University of Toronto

  September 8, 2014

   · 

  4 min read
• Drug Development

  Vital Therapies, Inc. (VTI) Announces Management Addition; Enrollment In VTI-208 Phase 3 Trial Now 75 Percent Complete

  September 8, 2014

   · 

  4 min read
• Deals

  Momenta Pharmaceuticals, Inc. Exercises Option To Acquire Novel Antibodies From AnaptysBio, Inc.

  September 8, 2014

   · 

  4 min read
• BioMidwest

  PDL BioPharma, Inc. Announces Conversion Rate Adjustments For Convertible Notes

  September 8, 2014

   · 

  3 min read
• Business

  Phase Holographic Imaging Announces Collaboration Agreement With Northeastern University

  September 8, 2014

   · 

  2 min read
• Endo International plc Announces Launch Of Authorized Generic Of FORTESTA® Gel

  September 8, 2014

   · 

  7 min read
• Pharm Country

  Capstone Therapeutics Announces Digital Corporate Communication Channels

  September 8, 2014

   · 

  2 min read
• Pharm Country

  Transparency Life Sciences Awarded $1.4 Million NCATS SBIR Grant To Conduct Innovative Trial Of Lisinopril In Multiple Sclerosis

  September 8, 2014

   · 

  4 min read
• Policy

  Astellas Pharma Inc. Receives Notification From FDA Of Acceptance Of Filing Of Isavuconazole NDA For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis

  September 8, 2014

   · 

  2 min read